Last updated September 12, 2026
Key finding
Mean monthly adherence to blood glucose monitoring was significantly higher in the integrated care group than in the usual care group (87.60% vs. 76.47%; mean difference 11.17%, 95% CI 5.10% to 17.23%; P < 0.001)
This pilot trial evaluated a village doctor-led intervention combining financial incentives and telemedicine support for diabetes management in rural China, finding improved adherence to blood glucose monitoring.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This pilot trial evaluated a village doctor-led intervention combining financial incentives and telemedicine support for diabetes management in rural China, finding improved adherence to blood glucose monitoring.
Improving adherence to blood glucose monitoring is crucial for effective diabetes management, especially in rural areas where access to healthcare may be limited. This study suggests that integrating financial incentives with telemedicine can enhance patient engagement, potentially leading to better health outcomes in diabetes management.
Small sample size may limit generalizability. Short duration of the study may not capture long-term effects. Statistical significance was not achieved for key clinical outcomes.
Published in
Publication details and source links for this paper.
Qingqing Z, Chuanmeng Z, Jing Z, et al. Pilot trial of a village doctor-led intervention combining financial incentives and telemedicine support to improve diabetes management in rural China. BMC Geriatrics. 2026;26:973. doi:10.1186/s12877-026-07703-4
Monthly adherence to blood glucose monitoring significantly increased in the integrated care group by 11.17% (87.60% vs. 76.47%, p = 0.001).
No statistically significant difference in HbA1c reduction between groups (p = 0.199).
Fasting plasma glucose showed a decreasing trend but was not statistically significant (p = 0.330).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Telemedicine care, Usual care and 2-h postprandial glucose, Blood glucose, Fasting Plasma Glucose (FPG), and 1 more.
This study contributes evidence to
Primary intervention
Telemedicine care
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
8
Evidence pairs
1489
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence topic
matched_outcome
Related evidence
Evidence topic
Save evidence
Core evidence
The primary outcomes reported in this study.
Telemedicine care → 2-h postprandial glucose
Telemedicine care → 2-h postprandial glucose
Telemedicine care → Fasting Plasma Glucose (FPG)
Telemedicine care → Fasting Plasma Glucose (FPG)
Usual care → Fasting Plasma Glucose (FPG)
Usual care → Fasting Plasma Glucose (FPG)
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Usual care and HbA1c, Usual care and Fasting Glucose.
This study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Behavioral & Lifestyle
Curated evidence collections and hubs this study is part of.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies on Usual care
Contributes to Usual care evidence base.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
14 results
6 results
14 results
14 results
6 results
Generated from the study's connected evidence using Evidence Intelligence™.
Usual care may lower HbA1c.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.9 | weak positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Usual care for fasting plasma glucose (FPG).
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Strong | EvidenceScore™ 84.7 | neutral | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Telemedicine care for 2-h postprandial glucose.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
2-h postprandial glucose
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Telemedicine care for fasting plasma glucose (FPG).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
